Which factors affect the amount of chicken drink

Age: With the growth of chickens, the demand for water is also increasing. The quantity and quality of drinking water is also increasingly important for the performance of chickens. Any method that limits the amount of drinking water will affect the growth of chickens.

Gender: After one week of age, the amount of water consumed by the rooster and the proportion of water intake is higher than that of the hen.

Ambient temperature: Above 21°C, when the temperature rises by 1°C, the bird's drinking water will increase by 6-7%. The author suggests installing a water meter in each chicken house to record the daily drinking water amount and monitor the drinking water amount in time. Changes in drinking water were found and appropriate measures were taken in time.

Drinking water temperature: Under normal circumstances, we consider the temperature of drinking water in addition to the first week of chicks and drinking water immunization, other time rarely considered. Some experts have found that drinking water temperature is better at 10°C, and water temperature above 26.7°C will affect the amount of water the chicken drinks. In hot season, if the amount of drinking water exceeds 24°C, measures must be taken to reduce the drinking water temperature. The drinking water pipeline can be passed through a cold water tank or blown with cold air to lower the temperature of the drinking water; so that the water tank and the water pipe can be placed under the ground, the water temperature can not be too high, and the exposed water tank or water pipe should have good heat insulation performance and avoid Direct sunlight; also can often use cold water to wash the drinking water pipe in the house.

Ibrutinib is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK) that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrom's macroglobulinemia, a form of non-Hodgkin's lymphoma.
Ibrutinib is used to treat chronic lymphocytic leukemia, Waldenstrom's macroglobulinemia, and as a second-line treatment for mantle cell lymphoma, and marginal zone lymphoma.
We produce a series of complete intermediates for Ibrutinib, intermediate I (CAS No. 330786-24-8) and intermediate II (CAS No. 143900-44-1) etc.
All of our products are with stable production and strict quality control, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.


Pharmaceutical Intermediates

Ibrutinib Intermediates

Ibrutinib Intermediates,Cas 330786-24-8,Cas 143900-44-1,High Purity Ibrutinib Intermediates

Nanjing Sunshine Biotech Co., Ltd , https://www.sunshine-bio.com